Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Oct;83(10):2315-2316.
doi: 10.1111/bcp.13337. Epub 2017 Jul 4.

Concomitant medications and obstructive sleep apnoea

Affiliations
Comment

Concomitant medications and obstructive sleep apnoea

François Montastruc et al. Br J Clin Pharmacol. 2017 Oct.
No abstract available

Keywords: adverse drug reactions; concomitant medications; drug safety; obstructive sleep apnoea; pharmacovigilance.

PubMed Disclaimer

Comment in

  • Drugs and obstructive sleep apnoea.
    Revol B, Jullian-Desayes I, Pepin JL, Joyeux-Faure M. Revol B, et al. Br J Clin Pharmacol. 2017 Oct;83(10):2317-2318. doi: 10.1111/bcp.13361. Epub 2017 Jul 14. Br J Clin Pharmacol. 2017. PMID: 28707329 Free PMC article. No abstract available.

Comment on

  • Impact of concomitant medications on obstructive sleep apnoea.
    Jullian-Desayes I, Revol B, Chareyre E, Camus P, Villier C, Borel JC, Pepin JL, Joyeux-Faure M. Jullian-Desayes I, et al. Br J Clin Pharmacol. 2017 Apr;83(4):688-708. doi: 10.1111/bcp.13153. Epub 2016 Nov 24. Br J Clin Pharmacol. 2017. PMID: 27735059 Free PMC article. Review.

References

    1. Jullian‐Desayes I, Revol B, Chareyre E, Camus P, Villier C, Borel JC, et al. Impact of concomitant medications on obstructive sleep apnoea. Br J Clin Pharmacol 2017; 83: 688–708. - PMC - PubMed
    1. Vial T. French pharmacovigilance: missions, organization and perspectives. Therapie 2016; 71: 143–150. - PubMed
    1. Linselle M, Montastruc F, Jantzen H, Valnet‐Rabier MB, Haramburu F, et al. Drugs and sleep apneas? A review of the French Pharmacovigilance database. Therapie 2015; 70: 347–350. - PubMed
    1. Bate A, Lindquist M, Edwards IR. The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO database. Fundam Clin Pharmacol 2008; 22: 127–140. - PubMed
    1. Faillie JL, Montastruc F, Montastruc JL, Pariente A. Pharmacoepidemiology and its input to pharmacovigilance. Therapie 2016; 71: 211–260. - PubMed

LinkOut - more resources